Detection of colon cancer recurrences during follow-up care by general practitioners vs surgeons

Abstract Background In the I CARE study, colon cancer patients were randomly assigned to receive follow-up care from either a general practitioner (GP) or a surgeon. Here, we address a secondary outcome, namely, detection of recurrences and effect on time to detection of transferring care from surgeon to GP. Methods Pattern, stage, and treatment of recurrences were described after 3 years. Time to event was defined as date of surgery, until date of recurrence or last follow-up, with death as competing event. Effects on time to recurrence and death were estimated as hazard ratios (HRs) using Cox regression. Restricted mean survival times were estimated. Results Of 303 patients, 141 were randomly assigned to the GP and 162 to the surgeon. Patients were male (67%) with a mean age of 68.0 (8.4) years. During follow-up, 46 recurrences were detected; 18 (13%) in the GP vs 28 (17%) in the surgeon group. Most recurrences were detected via abnormal follow-up tests (74%) and treated with curative intent (59%). Hazard ratio for recurrence was 0.75 (95% confidence interval [CI] = 0.41 to 1.36) in GP vs surgeon group. Patients in the GP group remained in the disease-free state slightly longer (2.76 vs 2.71 years). Of the patients, 38 died during follow-up; 15 (11%) in the GP vs 23 (14%) in the surgeon group. Of these, 21 (55%) deaths were related to colon cancer. There were no differences in overall deaths between the groups (HR = 0.76, 95% CI = 0.39 to 1.46). Conclusion Follow-up provided by GPs vs surgeons leads to similar detection of recurrences. Also, no differences in mortality were found.

[1]  F. H. Beverdam,et al.  Patient experiences of GP-led colon cancer survivorship care: a Dutch mixed-methods evaluation , 2022, The British journal of general practice : the journal of the Royal College of General Practitioners.

[2]  M. Jefford,et al.  Improved models of care for cancer survivors , 2022, The Lancet.

[3]  K. V. van Asselt,et al.  Delivering colon cancer survivorship care in primary care; a qualitative study on the experiences of general practitioners , 2022, BMC Primary Care.

[4]  J. Wind,et al.  Recruitment challenges to the I CARE study: a randomised trial on general practitioner-led colon cancer survivorship care , 2021, BMJ Open.

[5]  J. Wind,et al.  Effect of general practitioner-led versus surgeon-led colon cancer survivorship care, with or without eHealth support, on quality of life (I CARE): an interim analysis of 1-year results of a randomised, controlled trial. , 2021, The Lancet. Oncology.

[6]  R. Verhoeven,et al.  Disease recurrence after colorectal cancer surgery in the modern era: a population-based study , 2021, International Journal of Colorectal Disease.

[7]  J. Emery,et al.  Outcomes of cancer survivorship education and training for primary care providers: a systematic review , 2021, Journal of Cancer Survivorship.

[8]  N. D. de Wit,et al.  GP involvement after a cancer diagnosis; patients’ call to improve decision support , 2020, BJGP open.

[9]  K. V. van Asselt,et al.  Survivorship care for cancer patients in primary versus secondary care: a systematic review , 2020, Journal of Cancer Survivorship.

[10]  S. Qaderi,et al.  Major differences in follow-up practice of patients with colorectal cancer; results of a national survey in the Netherlands , 2020, BMC Cancer.

[11]  S. Guraya Pattern, Stage, and Time of Recurrent Colorectal Cancer After Curative Surgery. , 2019, Clinical colorectal cancer.

[12]  H. Uno,et al.  Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio , 2017, JAMA oncology.

[13]  C. Johansen,et al.  Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. , 2016, The Cochrane database of systematic reviews.

[14]  R. A’Hern Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials? , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Jon Adams,et al.  The role of the GP in follow-up cancer care: a systematic literature review , 2016, Journal of Cancer Survivorship.

[16]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[17]  J. Wardle,et al.  The expanding role of primary care in cancer control. , 2015, The Lancet. Oncology.

[18]  J. Wind,et al.  Improving care after colon cancer treatment in The Netherlands, personalised care to enhance quality of life (I CARE study): study protocol for a randomised controlled trial , 2015, Trials.

[19]  K. Augestad,et al.  Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial , 2013, BMJ Open.

[20]  O. Aalen,et al.  Survival and Event History Analysis: A Process Point of View , 2008 .

[21]  Y. Cho,et al.  Local recurrence after curative resection in patients with colon and rectal cancers , 2008, International Journal of Colorectal Disease.

[22]  Peter Congdon,et al.  Survival and Event History Analysis , 2007 .

[23]  J. Perlmutter,et al.  From Cancer Patient to Cancer Survivor: Lost in Translation , 2006 .

[24]  C. Silagy,et al.  General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial , 2006, British Journal of Cancer.

[25]  T. Whelan,et al.  Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  David Machin,et al.  Sample Size Tables for Clinical Studies , 1997 .

[27]  D. Mant,et al.  Routine follow up of breast cancer in primary care: randomised trial , 1996, BMJ.

[28]  J. Wind,et al.  Follow-up of colon cancer patients; causes of distress and need for supportive care: Results from the ICARE Cohort Study. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  J. Emery,et al.  The role of primary care in early detection and follow-up of cancer , 2014, Nature Reviews Clinical Oncology.